Home › Companies › PERSPECTIVE THERAPEUTICS INC. › 2024-2025

PERSPECTIVE THERAPEUTICS INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and PERSPECTIVE THERAPEUTICS INC.’s Form 8-K, filed May 28, 2025 (Item 5.07 on EDGAR). Page generated October 18, 2026.

  • 7Reported items
  • 110Asset managers
  • 929Fund votes
  • May 28, 2025Meeting date

Results at a glance

Meeting of May 28, 2025: 7 items on PERSPECTIVE THERAPEUTICS INC.’s Form 8-K, filed May 28, 2025: 2 approved · 5 without a stated outcome.

Material dissent

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2024-2025 2025-2026

Explore PERSPECTIVE THERAPEUTICS INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by PERSPECTIVE THERAPEUTICS INC.

These tallies are PERSPECTIVE THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 28, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

PERSPECTIVE THERAPEUTICS INC. — official shareholder meeting results, meeting held May 28, 2025
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Lori A. Woods 48,265,909---- 4,302,1268,282,256 92%Not verified—
Elect Director: Heidi Henson 41,847,883---- 10,720,1528,282,256 80%Not verified—
Elect Director: Frank Morich, M.D., Ph.D. 35,430,823---- 17,137,2128,282,256 67%Not verified—
Elect Director: Johan (Thijs) Spoor 51,907,815---- 660,2208,282,256 99%Not verified—
Elect Director: Robert Froman Williamson, III 41,915,458---- 10,652,5778,282,256 80%Not verified—
2. The Auditor Ratification Proposal 59,126,1401,584,010140,141 ---- 97%Approved—
3. Say on Pay Proposal 38,730,18513,686,122151,728 --8,282,256 74%Approved—

Source: PERSPECTIVE THERAPEUTICS INC., Form 8-K, filed with the SEC on May 28, 2025 — read the filing on EDGAR.

How asset managers voted at the PERSPECTIVE THERAPEUTICS INC. 2024-2025 meeting

Each item below shows how the 110 asset managers that disclosed a PERSPECTIVE THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of PERSPECTIVE THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Elect Director: Frank Morich, M.D., Ph.D.

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

67% Majority: yes · of votes cast

FOR 67%WITHHELD
FOR: 35,430,823WITHHELD: 17,137,212
Details: description as filed, official tally, votes by 36 asset managers

Description as filed by funds: To consider and vote on a proposal to elect five directors named in the Proxy Statement, each to hold office until the Company's 2026 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified: Frank Morich, M.D., Ph.D.

PERSPECTIVE THERAPEUTICS INC.’s own tally for this item (“Elect Director: Frank Morich, M.D., Ph.D.”): 35,430,823 for, 17,137,212 withheld, per its Form 8-K filed May 28, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 67% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 36 asset managers below reported 4,866,303 for, 9,383,498 withheld, 1,376,324 abstained.

FORWITHHOLD
FOR: 4,866,303ABSTAIN: 1,376,324WITHHOLD: 9,383,498
Largest asset managers voting on “To consider and vote on a proposal to elect five directors named in the Proxy Statement, each to hold office u” at PERSPECTIVE THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Fidelity1,055,4720 08,098,869Mixed
Vanguard2,954,3760 00For
BlackRock00 1,295,4700Abstain
TIAA00 01,077,235Withhold
Charles Schwab434,0850 00For
Equitable41,8390 083,399Mixed
BRIDGEWAY FUNDS INC125,0000 00For
Federated Hermes68,1610 00For
QUANTITATIVE MASTER SERIES LLC00 66,4890Abstain
Lincoln Financial37,4000 00For
Global X00 032,349Withhold
Northern Trust00 029,607Withhold
Goldman Sachs27,0340 00For
AIG/SunAmerica26,4830 00For
ETFis Series Trust I26,4400 00For
Pacific Life00 020,167Withhold
John Hancock20,0770 00For
Nationwide00 013,974Withhold
Bridge Builder Trust00 13,7610Abstain
ProShares12,6930 00For
Voya00 010,504Withhold
DWS8,2050 00For
SEI00 07,700Withhold
Columbia Threadneedle5,7350 00For
Calvert00 05,476Withhold

Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.

2. Elect Director: Heidi Henson

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

80% Majority: yes · of votes cast

FOR 80%WITHHELD
FOR: 41,847,883WITHHELD: 10,720,152
Details: description as filed, official tally, votes by 36 asset managers

Description as filed by funds: To consider and vote on a proposal to elect five directors named in the Proxy Statement, each to hold office until the Company's 2026 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified: Heidi Henson

PERSPECTIVE THERAPEUTICS INC.’s own tally for this item (“Elect Director: Heidi Henson”): 41,847,883 for, 10,720,152 withheld, per its Form 8-K filed May 28, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 80% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 36 asset managers below reported 7,472,349 for, 8,153,776 withheld.

FORWITHHOLD
FOR: 7,472,349WITHHOLD: 8,153,776
Largest asset managers voting on “To consider and vote on a proposal to elect five directors named in the Proxy Statement, each to hold office u” at PERSPECTIVE THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Fidelity1,055,4720 08,098,869Mixed
Vanguard2,954,3760 00For
BlackRock1,295,4700 00For
TIAA1,077,2350 00For
Charles Schwab434,0850 00For
Equitable83,3990 041,839Mixed
BRIDGEWAY FUNDS INC125,0000 00For
Federated Hermes68,1610 00For
QUANTITATIVE MASTER SERIES LLC66,4890 00For
Lincoln Financial37,4000 00For
Global X32,3490 00For
Northern Trust29,6070 00For
Goldman Sachs27,0340 00For
AIG/SunAmerica26,4830 00For
ETFis Series Trust I26,4400 00For
Pacific Life20,1670 00For
John Hancock20,0770 00For
Nationwide6,5900 07,384Mixed
Bridge Builder Trust13,7610 00For
ProShares12,6930 00For
Voya10,5040 00For
DWS8,2050 00For
SEI7,7000 00For
Columbia Threadneedle5,7350 00For
Calvert00 05,476Withhold

Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.

3. Elect Director: Johan (Thijs) Spoor

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 51,907,815WITHHELD: 660,220
Details: description as filed, official tally, votes by 36 asset managers

Description as filed by funds: To consider and vote on a proposal to elect five directors named in the Proxy Statement, each to hold office until the Company's 2026 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified: Johan (Thijs) Spoor

PERSPECTIVE THERAPEUTICS INC.’s own tally for this item (“Elect Director: Johan (Thijs) Spoor”): 51,907,815 for, 660,220 withheld, per its Form 8-K filed May 28, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 36 asset managers below reported 15,626,125 for.

FOR
FOR: 15,626,125
Largest asset managers voting on “To consider and vote on a proposal to elect five directors named in the Proxy Statement, each to hold office u” at PERSPECTIVE THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Fidelity9,154,3410 00For
Vanguard2,954,3760 00For
BlackRock1,295,4700 00For
TIAA1,077,2350 00For
Charles Schwab434,0850 00For
Equitable125,2380 00For
BRIDGEWAY FUNDS INC125,0000 00For
Federated Hermes68,1610 00For
QUANTITATIVE MASTER SERIES LLC66,4890 00For
Lincoln Financial37,4000 00For
Global X32,3490 00For
Northern Trust29,6070 00For
Goldman Sachs27,0340 00For
AIG/SunAmerica26,4830 00For
ETFis Series Trust I26,4400 00For
Pacific Life20,1670 00For
John Hancock20,0770 00For
Nationwide13,9740 00For
Bridge Builder Trust13,7610 00For
ProShares12,6930 00For
Voya10,5040 00For
DWS8,2050 00For
SEI7,7000 00For
Columbia Threadneedle5,7350 00For
Calvert5,4760 00For

Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.

4. Elect Director: Lori A. Woods

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

92% Majority: yes · of votes cast

FOR 92%
FOR: 48,265,909WITHHELD: 4,302,126
Details: description as filed, official tally, votes by 36 asset managers

Description as filed by funds: To consider and vote on a proposal to elect five directors named in the Proxy Statement, each to hold office until the Company's 2026 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified: Lori A. Woods

PERSPECTIVE THERAPEUTICS INC.’s own tally for this item (“Elect Director: Lori A. Woods”): 48,265,909 for, 4,302,126 withheld, per its Form 8-K filed May 28, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 92% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 36 asset managers below reported 15,059,862 for, 565,659 withheld, 604 abstained.

FOR
FOR: 15,059,862ABSTAIN: 604WITHHOLD: 565,659
Largest asset managers voting on “To consider and vote on a proposal to elect five directors named in the Proxy Statement, each to hold office u” at PERSPECTIVE THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Fidelity9,154,3410 00For
Vanguard2,954,3760 00For
BlackRock1,295,4700 00For
TIAA1,077,2350 00For
Charles Schwab00 0434,085Withhold
Equitable125,2380 00For
BRIDGEWAY FUNDS INC125,0000 00For
Federated Hermes00 068,161Withhold
QUANTITATIVE MASTER SERIES LLC66,4890 00For
Lincoln Financial37,4000 00For
Global X00 032,349Withhold
Northern Trust29,6070 00For
Goldman Sachs27,0340 00For
AIG/SunAmerica26,4830 00For
ETFis Series Trust I26,4400 00For
Pacific Life20,1670 00For
John Hancock20,0770 00For
Nationwide6,5900 07,384Mixed
Bridge Builder Trust13,7610 00For
ProShares12,6930 00For
Voya00 010,504Withhold
DWS8,2050 00For
SEI00 07,700Withhold
Columbia Threadneedle5,7350 00For
Calvert00 05,476Withhold

Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.

5. Elect Director: Robert Froman Williamson, III

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

80% Majority: yes · of votes cast

FOR 80%WITHHELD
FOR: 41,915,458WITHHELD: 10,652,577
Details: description as filed, official tally, votes by 36 asset managers

Description as filed by funds: To consider and vote on a proposal to elect five directors named in the Proxy Statement, each to hold office until the Company's 2026 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified: Robert Froman Williamson, III

PERSPECTIVE THERAPEUTICS INC.’s own tally for this item (“Elect Director: Robert Froman Williamson, III”): 41,915,458 for, 10,652,577 withheld, per its Form 8-K filed May 28, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 80% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 36 asset managers below reported 7,514,188 for, 8,111,937 withheld.

FORWITHHOLD
FOR: 7,514,188WITHHOLD: 8,111,937
Largest asset managers voting on “To consider and vote on a proposal to elect five directors named in the Proxy Statement, each to hold office u” at PERSPECTIVE THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Fidelity1,055,4720 08,098,869Mixed
Vanguard2,954,3760 00For
BlackRock1,295,4700 00For
TIAA1,077,2350 00For
Charles Schwab434,0850 00For
Equitable125,2380 00For
BRIDGEWAY FUNDS INC125,0000 00For
Federated Hermes68,1610 00For
QUANTITATIVE MASTER SERIES LLC66,4890 00For
Lincoln Financial37,4000 00For
Global X32,3490 00For
Northern Trust29,6070 00For
Goldman Sachs27,0340 00For
AIG/SunAmerica26,4830 00For
ETFis Series Trust I26,4400 00For
Pacific Life20,1670 00For
John Hancock20,0770 00For
Nationwide6,5900 07,384Mixed
Bridge Builder Trust13,7610 00For
ProShares12,6930 00For
Voya10,5040 00For
DWS8,2050 00For
SEI7,7000 00For
Columbia Threadneedle5,7350 00For
Calvert00 05,476Withhold

Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.

6. TO CONSIDER AND VOTE ON A PROPOSAL TO APPROVE, ON A NON-BINDING ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED…

No official matchFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

Combines 4 wordings of this item as funds reported it.

49.2% Fund and manager reports combined; may count the same shares twice · no official result

FORAGAINST
Details: description as filed, votes by 110 asset managers

Description as filed by funds: TO CONSIDER AND VOTE ON A PROPOSAL TO APPROVE, ON A NON-BINDING ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 36 asset managers voting on “TO CONSIDER AND VOTE ON A PROPOSAL TO APPROVE, ON A NON-BINDING ADVISORY BASIS, THE COMPENSATION OF THE COMPAN” at PERSPECTIVE THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Fidelity09,154,341 00Against
Vanguard2,954,3760 00For
BlackRock1,295,4700 00For
TIAA1,077,2350 00For
Charles Schwab434,0850 00For
Equitable83,39941,839 00Mixed
BRIDGEWAY FUNDS INC0125,000 00Against
Federated Hermes68,1610 00For
QUANTITATIVE MASTER SERIES LLC66,4890 00For
Lincoln Financial37,4000 00For
Global X32,3490 00For
Northern Trust29,6070 00For
Goldman Sachs027,034 00Against
AIG/SunAmerica026,483 00Against
ETFis Series Trust I026,440 00Against
Pacific Life20,1670 00For
John Hancock020,077 00Against
Nationwide13,9740 00For
Bridge Builder Trust13,7610 00For
ProShares012,693 00Against
Voya010,504 00Against
DWS08,205 00Against
SEI7,7000 00For
Columbia Threadneedle05,735 00Against
Calvert05,476 00Against

Fund voting reports, all 36 managers: 6,140,638 for, 9,485,487 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 88 asset managers voting on “TO CONSIDER AND VOTE ON A PROPOSAL TO APPROVE, ON A NON-BINDING ADVISORY BASIS, THE COMPENSATION OF THE COMPAN” at PERSPECTIVE THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Fidelity09,707,530 00Against
DEERFIELD MANAGEMENT COMPANY, L.P.2,795,2130 00For
Avidity Partners Management LP2,197,2700 00For
Affinity Asset Advisors, LLC1,909,2110 00For
Octagon Capital Advisors LP1,744,8290 00For
BlackRock1,389,135999 00For
GEODE CAPITAL MANAGEMENT, LLC01,193,927 00Against
Nuveen1,085,8420 00For
Hills Bank & Trust Co1,023,6280 00For
State Street543,9512,678 00For
Velan Capital Investment Management LP500,0000 00For
Rock Springs Capital Management LP0444,383 00Against
Charles Schwab434,0850 00For
Citadel269,2360 00For
Northern Trust251,91924 00For
MELLON INVESTMENTS Corp0206,840 00Against
PORTLAND INVESTMENT COUNSEL INC.190,0000 00For
HighVista Strategies LLC131,1790 00For
BRIDGEWAY CAPITAL MANAGEMENT, LLC0125,000 00Against
MARSHALL WACE, LLP111,7300 00For
MONETA GROUP INVESTMENT ADVISORS LLC086,338 00Against
Federated Hermes68,1610 00For
Point72053,314 00Against
AllianceBernstein041,839 00Against
STATE OF WISCONSIN INVESTMENT BOARD037,554 00Against

Institutional-manager reports, all 88 managers: 14,794,217 for, 12,088,347 against. Showing the 25 largest; see all in the interactive database.

7. 2. The Auditor Ratification Proposal

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 2 wordings of this item as funds reported it.

97% Approved · of votes cast

FOR 97%
FOR: 59,126,140AGAINST: 1,584,010
Details: description as filed, official tally, votes by 36 asset managers

Description as filed by funds: To consider and vote on a proposal to ratify the appointment of WithumSmith+Brown, PC as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2025.

PERSPECTIVE THERAPEUTICS INC.’s own tally for this item (“2. The Auditor Ratification Proposal”): 59,126,140 for, 1,584,010 against — passed, per its Form 8-K filed May 28, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The stockholders of the Company ratified the appointment of WithumSmith+Brown, PC as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 36 asset managers below reported 15,626,125 for.

FOR
FOR: 15,626,125
Largest asset managers voting on “To consider and vote on a proposal to ratify the appointment of WithumSmith+Brown, PC as the independent regis” at PERSPECTIVE THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Fidelity9,154,3410 00For
Vanguard2,954,3760 00For
BlackRock1,295,4700 00For
TIAA1,077,2350 00For
Charles Schwab434,0850 00For
Equitable125,2380 00For
BRIDGEWAY FUNDS INC125,0000 00For
Federated Hermes68,1610 00For
QUANTITATIVE MASTER SERIES LLC66,4890 00For
Lincoln Financial37,4000 00For
Global X32,3490 00For
Northern Trust29,6070 00For
Goldman Sachs27,0340 00For
AIG/SunAmerica26,4830 00For
ETFis Series Trust I26,4400 00For
Pacific Life20,1670 00For
John Hancock20,0770 00For
Nationwide13,9740 00For
Bridge Builder Trust13,7610 00For
ProShares12,6930 00For
Voya10,5040 00For
DWS8,2050 00For
SEI7,7000 00For
Columbia Threadneedle5,7350 00For
Calvert5,4760 00For

Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.

Largest PERSPECTIVE THERAPEUTICS INC. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 74,228,334 shares outstanding at the time of that meeting.

Fund voting reports: top PERSPECTIVE THERAPEUTICS INC. shareholders by shares voted on “TO CONSIDER AND VOTE ON A PROPOSAL TO APPROVE, ON A NON-BINDING ADVISORY BASIS, THE…”, 2024-2025
#Asset manager % of shares outstanding
1Fidelity 12.33%
2Vanguard 3.98%
3BlackRock 1.75%
4TIAA 1.45%
5Charles Schwab 0.58%
6Equitable 0.17%
7BRIDGEWAY FUNDS INC 0.17%
8Federated Hermes 0.09%
9QUANTITATIVE MASTER SERIES LLC 0.09%
10Lincoln Financial 0.05%
Institutional-manager reports: top PERSPECTIVE THERAPEUTICS INC. shareholders by shares voted on “TO CONSIDER AND VOTE ON A PROPOSAL TO APPROVE, ON A NON-BINDING ADVISORY BASIS, THE…”, 2024-2025
#Asset manager % of shares outstanding
1Fidelity 13.08%
2DEERFIELD MANAGEMENT COMPANY, L.P. 3.77%
3Avidity Partners Management LP 2.96%
4Affinity Asset Advisors, LLC 2.57%
5Octagon Capital Advisors LP 2.35%
6BlackRock 1.87%
7GEODE CAPITAL MANAGEMENT, LLC 1.61%
8Nuveen 1.46%
9Hills Bank & Trust Co 1.38%
10State Street 0.74%

Reported PERSPECTIVE THERAPEUTICS INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

PERSPECTIVE THERAPEUTICS INC. holdings and ownership disclosed for the 2024-2025 proxy season
Holder % outstanding Disclosure
Lantheus Alpha Therapy, LLC 15.73% DEF14A
FMR (Fidelity) 13.54% 13F
FMR LLC 12.79% DEF14A
Chen Yu 10.66% 13G
Qatar Investment Authority 9.53% 13G
Avidity Partners Management LP 8.15% 13G
Millennium Management LLC 6.59% 13G
BlackRock 5.35% 13F
Vanguard Group 4.13% 13F
Morgan Stanley 2.10% 13F

Percentages above are of 74,228,334 shares outstanding, as reported by PERSPECTIVE THERAPEUTICS INC. on its Form 10-Q dated May 7, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from PERSPECTIVE THERAPEUTICS INC.’s 10-Q dated May 7, 2025. This page is a static snapshot rebuilt weekly on October 18, 2026; a live search always shows the current data.

At PERSPECTIVE THERAPEUTICS INC.'s shareholder meeting held May 28, 2025, in the 2024-2025 proxy season, 110 asset managers reported how they voted in their SEC Form N-PX filings, covering 929 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. PERSPECTIVE THERAPEUTICS INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — TO CONSIDER AND VOTE ON A PROPOSAL TO APPROVE, ON A NON-BINDING ADVISORY BASIS, THE… — the reporting funds and managers cast 49.2% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). Fund and manager reports are combined in it and may count the same shares twice: it adds fund reports to institutional-manager reports, which can cover the same shares. It is not the company's certified result.

PERSPECTIVE THERAPEUTICS INC. proxy season coverage: 2024-2025 (this page) · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.